Letter: colorectal cancer surveillance in inflammatory bowel disease-a call for systematic reform
- PMID: 33745168
- DOI: 10.1111/apt.16284
Letter: colorectal cancer surveillance in inflammatory bowel disease-a call for systematic reform
Comment on
-
Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.Aliment Pharmacol Ther. 2021 Jan;53(2):291-301. doi: 10.1111/apt.16155. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159472 Free PMC article.
References
REFERENCES
-
- Gordon C, Chee D, Hamilton B, et al. Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2021;53:291-301.
-
- Mahmoud R, Itzkowitz SH. Editorial: missed opportunities to detect colorectal cancer in inflammatory bowel disease-getting to the root. Aliment Pharmacol Ther. 2021;53:335-336.
-
- Prentice R, Hollingsworth L, Middleton C, Wilson M, Kannuthurai S, Wilson J. IBD Clinical - adherence with Australian colorectal cancer colonoscopic surveillance guidelines in patients with inflammatory bowel disease at an Australian tertiary centre. J Gastroenterol Hepatol. 2019;34:115-165.
-
- Council AGNHaMR. Clinical Practice Guidelines for Survellience Colonoscopy. Australian Clinical Practice Guidelines: Australian Government; 2019.
-
- Symonds EL, Simpson K, Coats M, et al. A nurse-led model at public academic hospitals maintains high adherence to colorectal cancer surveillance guidelines. Med J Aust. 2018;208:492-496.